Keymed Biosciences Co.ltd

This study tested an investigational injectable drug called CM310 for teenagers with moderate-to-severe eczema. The main goal was to see if the drug could significantly clear skin and reduce itching compared to a placebo. It was a large, late-stage trial involving 180 participant…

This first-in-human study tested a new drug called CM512 to see if it is safe for people. It involved both healthy volunteers and patients with moderate to severe eczema. The main goal was to check for side effects and see how the drug moves through the body at different doses.